ImmunoPrecise Antibodies Ltd. (HYFT) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.39 (+6.11%), Market cap $0.06B, 52-week low–high $0.49 ~ $3.20.
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Financial statements, price targets, institutional (13F) holdings and related news for ImmunoPrecise Antibodies Ltd. are updated in real time on BlackAll Trade.
ImmunoPrecise Antibodies Ltd. trades at $1.39 (+6.11%). Real-time quotes and charts are available on BlackAll Trade.
ImmunoPrecise Antibodies Ltd. has a market cap of about $0.06B.
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery an